Evaluation of the national immunisation programme in the Netherlands: Immunity to diphtheria, tetanus, poliomyelitis, measles, mumps, rubella and Haemophilus influenzae type b

Vaccine

Volumn 21, Issue 7-8, 2003, Pages 716-720

  De Melker, H E ^a   Van den Hof, S ^a   Berbers, G A M ^a   Conyn van Spaendonck, M A E ^a  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

Immunisation programmes; Seroepidemiology; Serumbank; Vaccine preventable diseases

Indexed keywords

DIPHTHERIA VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; MEASLES VACCINE; MUMPS VACCINE; POLIOMYELITIS VACCINE; RUBELLA VACCINE; TETANUS TOXOID;

ADOLESCENT; ADULT; AGED; BACTERIAL INFECTION; CELLULAR IMMUNITY; CHILD; COHORT ANALYSIS; CONFERENCE PAPER; DIPHTHERIA; DRUG EFFICACY; DRUG SCREENING; EVALUATION; HAEMOPHILUS INFLUENZAE TYPE B; HEALTH PROGRAM; HIGH RISK POPULATION; HUMAN; HUMAN EXPERIMENT; IMMUNIZATION; IMMUNOASSAY; MEASLES; MEASLES VACCINATION; MEMORY CELL; MUMPS; NETHERLANDS; NEWBORN; NORMAL HUMAN; POPULATION; PRIORITY JOURNAL; RUBELLA; SEROPREVALENCE; TETANUS PROPHYLAXIS; VACCINATION;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; COMMUNICABLE DISEASE CONTROL; COMMUNICABLE DISEASES; DIPHTHERIA; HAEMOPHILUS INFECTIONS; HAEMOPHILUS INFLUENZAE TYPE B; HUMANS; IMMUNIZATION PROGRAMS; INFANT; INFANT, NEWBORN; MASS IMMUNIZATION; MEASLES; MIDDLE AGED; MUMPS; NATIONAL HEALTH PROGRAMS; NETHERLANDS; POLIOMYELITIS; PROGRAM EVALUATION; RUBELLA; TETANUS;

EID: 0037472396     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(02)00587-X     Document Type: Conference Paper

References (14)

1. de Melker H.E., Berbers G.A.M., Nagelkerke N.J.D., Conyn-van Spaendonck M.A.E. Diphtheria antitoxin levels in The Netherlands: a population-based study. Emerg. Infect. Dis. 5:1999;694-700.
2. de Melker H.E., van de Hof S., Berbers G.A.M., Nagelkerke N.J.D., Rümke H.C., Conyn-van Spaendonck M.A.E. A population-based study on tetanus immunity in The Netherlands. Vaccine. 18:1999;100-108.
3. Conyn-van Spaendonck M.A.E., de Melker H.E., Abbink F., Elzinga-Gholizadea N., Kimman T.G., van Loon A.M. Immunity against poliomyelitis in The Netherlands. Am. J. Epidemiol. 153:2001;207-214.
4. van den Hof S., Berbers G.A.M., de Melker H.E., Conyn-van Spaendonck M.A.E. Seroepidemiology of measles antibodies in The Netherlands, a cross-sectional study in a national sample and in municipalities with low vaccine coverage. Vaccine. 18:1999;931-940.
5. de Haas R., van den Hof S., Berbers G.A.M., de Melker H.E., Conyn-van Spaendonck M.A.E. Prevalence of antibodies against rubella virus in The Netherlands 9 years after changing from selective to mass vaccination. Epidemiol. Infect. 123:1999;263-270.
6. van den Hof S., de Melker H.E., Berbers G.A.M., van der Kraak P.H., Conyn-van Spaendonck M.A.E. Antibodies to Haemophilus influenzae type b a few years after the introduction of routine vaccination. Clin. Infect. Dis. 32:2001;2-8.
7. de Melker H.E., Conyn-van Spaendonck M.A.E. Immunosurveillance and the evaluation of national immunisation programmes: a population-based approach. Epidemiol. Infect. 121:1998;637-643.
8. de Melker H.E., Versteegh F.G.A., Conyn-van Spaendonck M.A.E., Elvers L.H., Berbers G.A.M., van der Zee A.et al. Specificity and sensitivity of high levels of IgG antibodies against pertussis toxin in a single serum for diagnosis of infection with Bordetella pertussis. J. Clin. Microbiol. 38:2000;800-806.
9. de Melker H.E., Nagelkerke N.J.D., Conyn-van Spaendonck M.A.E. Non-participation in a population-based seroprevalence study of vaccine-preventable diseases. Epidemiol. Infect. 124:2000;255-262.
10. Breukels M.A., Spanjaard L., Sanders L.A., Rijkers G.T. Immunological characterization of conjugated Haemophilus influenzae type b vaccine failure in infants. Clin. Infect. Dis. 32:2001;1700-1705.
11. van den Hof S., Meffre C.M.E., Conyn-van Spaendonck M.A.E., Woonink F., de Melker H.E., van Binnendijk R.S. Measles outbreak in a community with very low vaccine coverage, The Netherlands. Emerg. Infect. Dis. 6:2001;593-597.
12. Oostvogel P.M., van Wijngaarden J.K., van der Avoort H.G.A.M., Mulders M.N., Conyn-van Spaendonck M.A.E., Rümke H.C.et al. Poliomyelitis outbreak in an unvaccinated community in The Netherlands, 1992-1993. Lancet. 344:1994;665-670.
13. Mellinger A.K., Cragan J.D., Atkinson W., Williams W.W., Kleger B., Kimber R.G.et al. High incidence of congenital rubella syndrome after a rubella outbreak. Pediatr. Infect. Dis. J. 14:1995;573-578.
14. Panagiotopoulos T., Antoniadou I., Valassi-Adam E. Increase in congenital rubella occurrence after immunisation in Greece: retrospective survey and systematic review. BMJ. 319:1999;1462-1467.